Position statement of expert panel of the Polish Allergology Sociey on the management of patients with bronchial asthma and allergic diseases during SARS-Cov-2 pandemics. Update 1.06.2020

IF 0.2 Q4 ALLERGY

Alergologia Polska - Polish Journal of Allergology Pub Date : 2020-01-01 DOI:10.5114/pja.2020.99242

M. Kowalski, Z. Bartuzi, A. Bręborowicz, E. Cichocka-Jarosz, M. Czarnecka-Operacz, J. Kruszewski, M. Kulus, M. Kupczyk, M. Moniuszko, M. Niedoszytko, M. Nittner-Marszalska, R. Nowicki, B. Rogala, M. Chałubiński

{"title":"Position statement of expert panel of the Polish Allergology Sociey \non the management of patients with bronchial asthma and allergic diseases during SARS-Cov-2 pandemics. Update 1.06.2020","authors":"M. Kowalski, Z. Bartuzi, A. Bręborowicz, E. Cichocka-Jarosz, M. Czarnecka-Operacz, J. Kruszewski, M. Kulus, M. Kupczyk, M. Moniuszko, M. Niedoszytko, M. Nittner-Marszalska, R. Nowicki, B. Rogala, M. Chałubiński","doi":"10.5114/pja.2020.99242","DOIUrl":null,"url":null,"abstract":"The Polish Allergology Society is one of the first to convene a panel of experts, who on March 30, 2020 presented a position on the management of patients with asthma and allergic diseases during the SARS-CoV-2 pandemic Most of the recommendations and opinions presented in this position remain valid until now However, the dynamically changing epidemiological situation associated with SARS-CoV-2 infection poses new challenges for physicians in the care of asthma and allergic diseases Numerous published clinical observations and studies provide new information on asthma and allergic diseases in relation to the COVID-19 pandemic The current document contains new recommendations in line with available knowledge and taking into ac-count the views of other national and international organizations and societies","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":"1 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alergologia Polska - Polish Journal of Allergology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/pja.2020.99242","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

Abstract

The Polish Allergology Society is one of the first to convene a panel of experts, who on March 30, 2020 presented a position on the management of patients with asthma and allergic diseases during the SARS-CoV-2 pandemic Most of the recommendations and opinions presented in this position remain valid until now However, the dynamically changing epidemiological situation associated with SARS-CoV-2 infection poses new challenges for physicians in the care of asthma and allergic diseases Numerous published clinical observations and studies provide new information on asthma and allergic diseases in relation to the COVID-19 pandemic The current document contains new recommendations in line with available knowledge and taking into ac-count the views of other national and international organizations and societies

查看原文本刊更多论文

波兰过敏症学会专家小组关于SARS-Cov-2大流行期间支气管哮喘和过敏性疾病患者管理的立场声明更新1.06.2020

波兰过敏症学会是最早召集专家小组的组织之一，该小组于2020年3月30日就SARS-CoV-2大流行期间哮喘和过敏性疾病患者的管理提出了立场，该立场中提出的大多数建议和意见到目前为止仍然有效。与SARS-CoV-2感染相关的动态变化的流行病学形势给哮喘和过敏性疾病的护理医生带来了新的挑战。大量发表的临床观察和研究提供了与COVID-19大流行相关的哮喘和过敏性疾病的新信息。本文件根据现有知识并考虑到其他国家和国际组织和学会的观点，包含了新的建议

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Alergologia Polska - Polish Journal of Allergology ALLERGY-

自引率

50.00%

发文量

期刊介绍： Alergologia Polska - Polish Journal of Allergology is aimed mainly at allergologists, but also medical doctors working in related fields, such as otolaryngology, pulmonology, and dermatology. The main goal of the journal is to ensure rapid publication of important research papers and interesting case studies from the following areas: allergology, diagnostics, therapy of allergic diseases, in particular in the area of immunotherapy, rhinitis, asthma. The Editorial Board accepts for publication original papers, case studies and letters to the Editor. We also publish review articles (both commissioned and those agreed upon with the Editor-in-Chief), articles dealing with standards of medical practice, as well as special issues. The journal is published quarterly. We guarantee short review times (up to two weeks) and immediate publication on-line upon Editor acceptance.